Jul. 11 at 3:23 PM
$AFMD some more thoughts:
1. they went through all those troubles to register
$20M worth shares but eventually did not tap ATM -- seems diluting is worse than insolvency.
2. they at very least can raise sufficient capital through selling AFM13 to
$ARTV. Yet they did not tap the option. The collaboration is there and the data is stunning. There's no reason
$ARTV wouldn't pick up the pipeline for ~10m (cash+stock) -- which is an absolute bargain considering the pipeline costs hundreds of millions to develop.
3. they are in insolvency but they did not really layoff anyone (maybe until recently for Leland and Mueller) or pause/terminate any of their clinical trials. Actually doesn't seem like they are financially stressed.
4. ZERO update and radio silence since May. In any case, there should be updates from the company regarding current status (required by the law) and more exposure can attract attention for potential sales.
Not sure what is going on here. Something very unusual.
